The concept of multiple hormonal dysregulation

Acta Biomedica

Volumn 81, Issue SUPPL. 1, 2010, Pages 19-29

  Maggio, Marcello ^a,b   Cattabiani, Chiara ^b   Lauretani, Fulvio ^b   Ferrucci, Luigi ^c   Luci, Michele ^b   Valenti, Giorgio ^a   Ceda, Gianpaolo ^a,b  

^a UNIVERSITY OF PARMA   (Italy)

^b UNIVERSITY HOSPITAL OF PARMA   (Italy)

^c NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

Anabolic hormones; Frailty; Mortality

Indexed keywords

HYDROCORTISONE; PRASTERONE SULFATE; SOMATOMEDIN C; TESTOSTERONE;

AGED; AGING; ARTICLE; BLOOD; FRAIL ELDERLY; HUMAN; MORTALITY; PHYSIOLOGY;

AGED; AGING; DEHYDROEPIANDROSTERONE SULFATE; FRAIL ELDERLY; HUMANS; HYDROCORTISONE; INSULIN-LIKE GROWTH FACTOR I; MORTALITY; TESTOSTERONE;

EID: 77954949787     PISSN: 03924203     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (51)

1. Fried LP, Ferrucci L, Darer J, Williamson JD, Anderson G. Untangling the concepts of disability, frailty, and comorbidity: implications for improved targeting and care. J Gerontol A Biol Sci Med Sci 2000; 59 (3): 255-63.
2. Maggio M, Cappola AR, Ceda GP, et al. The hormonal pathway to frailty in older men. J Endocrinol Invest 2005; 28 (11 Suppl Proceedings): 15-9. Review
3. Lamberts SW, van den Beld AW, van der Lely AJ. The endocrinology of aging. Science 1997; 278 (5337): 419-24.
4. Ferrucci L, Maggio M, Bandinelli S, et al. Low testosterone levels and the risk of anemia in older men and women. Arch Intern Med 2006; 166 (13): 1380-8.
5. Rodriguez A, Muller DC, Metter EJ, et al. Aging, androgens, and metabolic syndrome in a longitudinal study of aging. J Clin Endocrinol Metab 2007; 92 (9): 3568-72
6. Ceda GP, Dall'Aglio E, Maggio M, et al. Clinical implications of the reduced activity of the GH-IGF-I axis in older men. J Endocrinol Invest 2005; 28 (11 suppl Proceedings): 96-100. Review
7. Roth GS, Lane MA, Ingram DK, et al. Biomarkers of caloric restriction may protect longevity in humans. Science 2002; 297 (5582): 811.
8. Fried LP, Tangen CM, Walston J, et al. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci 2001; 56 (3): M146-56.
9. Walston J, Hadley EC, Ferrucci L, et al. Research agenda for frailty in older adults: toward a better understanding of physiology and etiology: summary from the American Geriatrics Society/National Institute on aging research conference on frailty in older adults. J Am Geriatr Soc 2006; 54 (6): 991-1001.
10. Cappola AR, Xue QL, Fried LP. Multiple hormonal deficiencies in anabolic hormones are found in frail older women: the Women's Health and Aging studies. J Gerontol A Biol Sci Med Sci 2009; 64 (2): 243-8.
11. Leng SX, Cappola AR, Andersen RE, et al. Serum levels of insulin like growth factor-I (IGF-I) and dehydroepiandrosterone sulfate (DHEA-S) and their relatioships with serum interleukin-6, in the geriatric syndrome of frailty. Aging Clin Exp Res 2004; 16 (2): 153-7.
12. Voznesensky M, Walsh S, Dauser D, Brindisi J, Kenny AM. The association between dehydroepiandrosterone and frailty in older men and women. Age Ageing 2009; 38 (4): 401-6.
13. Cawthon PM, Ensrud KE, Laughlin GA, et al. Sex hormones and frailty in older men: the osteoporotic fractures in men (MrOS) study. J Clin Endocrinol Metab 2009; 94 (10): 3806-15.
14. Mohr BA, Bhasin S, Kupelian V, Araujo AB, O'Donnell AB, McKinlay JB. Testosterone, sex hormone-binding globulin and frailty in older men. J Am Geriatr Soc 2007; 55 (4): 548-55.
15. Puts MT, Visser M, Twisk JW, Deeg DJ, Lips P. Endocrine and inflammatory markers as predictors of frailty. Clin Endocrinol (Oxf) 2005; 63 (4): 403-11. DHEAS and mortality
16. Barrett-Connor E, Khaw KT, Yen SS. A prospective study of dehydroepiandrosterone sulfate, mortality, and cardiovascular disease. N Engl J Med 1986; 315 (24): 1519-24.
17. Mazat L, Lafont S, Berr C, et al. Prospective measurements of dehydroepiandrosterone sulfate in a cohort of elderly subjects: relationship to gender, subjective health, smoking habits, and 10-year mortality. Proc Natl Acad Sci 2001; 98 (14): 8145-50.
18. Cappola AR, Xue QL, Walston JD, et al. DHEAS levels and mortality in disabled older women: the Women's Health and Aging Study I. J Gerontol A Biol Sci Med Sci 2006; 61 (9): 957-62.
19. Cappola AR, O'Meara ES, Guo W, Bartz TM, Fried LP, Newmann AB. Trajectories of dehydroepiandrosterone sulfate predict mortality in older adults: the cardiovascular health study. J Gerontol A Biol Sci Med Sci 2009; 64 (12): 1268-74.
20. Tilvis RS, Kähönen M, Härkönen M. Dehydroepiandrosterone sulfate, diseases and mortality in a general aged population. Aging 1999; 11 (1): 30-4. Testosterone and mortality
21. Shores MM, Moceri VM, Gruenewald DA, Brodkin KI, Matsumoto AM, Kivlahan DR. Low testosterone is associated with decreased function and increased mortality risk: a preliminary study of men in geriatric rehabilitation unit. J Am Geriatr Soc 2004; 52: 2077-81.
22. Shores MM, Matsumoto AM, Sloan KL, Kivlahan DR. Low serum testosterone and mortality in male veterans. Arch Intern Med 2006; 166: 1660-65.
23. Khaw KT, Dowsett M, Folkerd E, et al. Endogenous testosterone and mortality due to all causes, cardiovascular disease, and cancer in men: european prospective investigation into cancer Norfolk (EPIC-Norfolk) prospective population study. Circulation 2007; 116: 2694-701.
24. Laughlin GA, Barrett-Connors E, Bergstrom J. Low serum testosterone and mortality in older men. J Clin Endocrinol Metab 2008; 93: 68-75.
25. Menke A, Guallar E, Rohrmann S, et al. Sex Steroid hormone concentrations and risk of death in US men. Am J Epidemiol 2010 Jan 18 (Epub ahead of print).
26. Smith GD, Ben-Shlomo Y, Beswick A, Yarnell J, Lightman S, Elwood P. Cortisol, testosterone, and coronary heart disease: prospective evidence from the Caerphilly Study. Circulation 2005; 112: 332-40.
27. Araujo A, Kupelian V, Page ST, Handelsman DJ, Bremner J, McKinlay JB. Sex steroids and all-cause and cause-specific mortality in men. Arch Intern Med 2007; 167: 1252-60.
28. Maggio M, Lauretani F, Ceda GP, et al. Relationship between low levels of anabolic hormones and 6-year mortality in older men: the aging in the Chianti Area (In-CHIANTI) study. Arch Intern Med 2007; 167 (20): 2249-54.
29. Bayes-Genis A, Conover CA, Schwartz RS. The insulin like growth factor axis: a review of atherosclerosis and restenosis. Circ Res 2000; 86: 25-130.
30. Conti E. Insulin like growth factor 1 as a vascular protective factor. Circulation 2004.
31. Baserga R. The insulin like growth factor 1 receptor: a key to tumor growth? Cancer Res 1995; 55 (2): 249-52.
32. Fürstenberger G. Insulin like growth factors and cancer. Lancet Oncol 2002; 3 (5): 298-302. Review
33. Samani A. The role of IGF system in cancer growth and metastasis: overview and recent insights. Endocr Rev 2007; 28 (1): 20-47. Review.
34. Anversa P. Aging and longevity: the Igf-1 enigma. Circ Res 2005; 97 (5): 411-4.
35. Roubenoff R, Parise H, Payette HA, et al. Cytokines, insulin like growth factor 1, sarcopenia and mortality in very old community-dwelling men and women: the Framingham Heart Study Am J Med 2003; 115: 429-35.
36. Arai Y, Takayama M, Gondo Y, et al. Adipose endocrine function, insulin like growth factor-1 axis and exceptional survival beyond 100 years of age. J Gerontol A Biol Sci Med Sci 2008; 63 (11): 1209-18.
37. Saydah S, Graubard B, Ballard-Barbash R, Berrigan D. Insulin like growth factors and subsequent risk of mortality in the United States. Am J Epidemiol 2007; 166 (5): 518-26.
38. Friedrich N, Haring R, Nauck M, et al. Mortality and serum insulin like growth factor-I and IGF binding protein 3 concentration. J Clin Endocrinol Metab 2009; 94 (5): 1732-9.
39. Laughlin GA, Barrett-Connor E, Criqui MH, Kritz-Silverstein D. The prospective association of serum insulin lik growth factor-I (IGF-I) and IGF-binding protein-1 levels with all cause and cardiovascular disease mortality in older adults: The Rancho Bernardo Study. J Clin Endocrinol Metab 2004; 89 (1): 114-20.
40. Brugts MP, van den Beld AW, Hofland LJ, et al. Low circulating insulin like growth factor-I bioactivity in elderly men is associated with increased mortality. J Clin Endocrinol Metab 2008; 93 (7): 2515-22.
41. Yamaguchi H, Komamura K, Choraku M, et al. Impact of serum insulin like growth factor-1 on early prognosis in acute myocardial infarction. Intern Med 2008; 47 (9): 819-25.
42. Cappola AR, Xue QL, Ferrucci L, Guralnik JM, Volpato S, Fried L. Insulin like growth factor I and Interleukin-6 contribute synergistically to disability and mortality in older women. J Clin Endocrinol Metab 2003; 88 (5): 2019-25.
43. Andreassen M, Kistorp C, Raymond I, et al. Plasma insulin like growth factor I as predictor of progression and all cause mortality in chronic heart failure. Growth Horm IGF Res 2009; 19 (6): 486-90.
44. Hu D, Pawlikowska L, Kanaya A, et al. Serum insulin like growth factor-1, binding protein 1 and 2 and mortality in older adults: the health, aging, and body composition study. J Am Geriatr Soc 2009; 57: 1213-8.
45. Kaplan R, McGinn AP, Pollak MN, et al. Total insulin like growth factor-I and insulin like growth factor binding protein levels, functional status, and mortality in older adults. J Am Geriat Soc 2008; 56: 652-60.
46. Raynaud Simon A, Lafort S, Berr C, Dartigues JF, Baulieu EE, Le Bouc Y. Plasma insulin like growth factor I levels in the elderly: relation to plasma dehydroepiandrosterone sulfate levels, nutritional status, health and mortality. Gerontology 2001; 47 (4): 198-206.
47. Andreassen M, Raymond I, Kistorp C, Hildebrandt P, Faber J, Kristensen LØ. IGF1 as predictor of all cause mortality and cardiovascular disease in an elderly population. Eur J Endocrinol 2009; 160 (1): 25-31.
48. Major JM, Laughlin GA, Kritz-Silvestein D, Wingard DL, Barrett-Connor E. Insulin like growth factor I and cancer mortality in older men. J Clin Endocrinol Metab 2010 in press Multiple Hormonal Dysregulation and accelerated aging
49. Jankowska EA, Biel B, Majda J, et al. Anabolic deficiency in men with chronic heart failure: prevalence and detrimental impact on survival. Circulation 2006; 114 (17): 1829-37.
50. Cappola AR, Maggio M, Ferrucci L. Is research on hormones and aging finished? No! Just started! J Gerontol A Biol Sci Med Sci 2008; 63 (7): 696-7.
51. Valenti G, Schwartz RS. Anabolic decline in the aging male: a situation of unbalanced syncrinology. Aging Male 2008; 11 (4): 153-6.